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I. Introduction
“The desire to have health and happy children is the most basic parental instinct.”1
Unfortunately, conceiving a healthy child is not always possible for some individuals because of
infertility or the presence of genes that may result in children with fatal conditions. Assisted
reproductive technology (ART) refers to technologies that enable biological reproduction of
humans without engaging in sexual intercourse. 2 With the advent of ART, a procedure known as
preimplantation genetic diagnosis (PGD) was developed to give patients the ability to screen for
specific genetic disorders in embryos created via in vitro fertilization (IVF).3 The whole purpose
of PGD was to offer a way for patients to completely avoid genetic diseases in their children. 4
However, one reason parents may decide to have children is to have a genetic connection. 5 A
survey conducted by the Genetics and Public Policy Centre indicated that three percent of
fertility clinics in the United States allow PGD for couples who want to screen an embryo for a
specific disease or disability so the child would have the same characteristic as the parents. 6 So,

1

Mark Popovsky, Jewish Perspectives on the Use of Preimplantation Genetic Diagnosis, 35 J.L. M ED. & ET HICS
699 (2007).
2 JUDIT H A REEN ET AL., FAMILY LAW 571 (6th ed. 2012).
3 Paul Brezina, Preimplantation Genetic Testing in the 21st Century: Uncharted Territory, 7 CLINICAL M ED,
available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888077/.
. INSIGHT S REPROD. HEALT H 17, 19 (2013).
4 Bergero v. Univ. of S. California Keck Sch. of Med., No. B200595, 2009 WL 946874, at *2 (Cal. Ct. App. Apr. 9,
2009).
5 ROSAMUND SCOT T , CHOOSING BET WEEN POSSIBLE LIVES: LAW AND ET HICS OF PRENAT AL AND PREIMPLANTATION
GENET IC DIAGNOSIS 12 (2007).
6 ISABEL KARPIN AND KRIST IN SAVELL , PERFECT ING PREGNANCY: LAW , DISABILIT Y, AND T HE FUTURE OF
REPRODUCT ION 236 (2012).
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is it that surprising that a couple with a genetic disorder, such as achondroplasia, would want to
have children with the disease as well?
Achondroplasia, a form of dwarfism, is an autosomal dominant genetic disorder; there are
roughly 1 in 8,000 to 10,000 births affected with this disorder. 7 Some of the characteristics of
individuals with achondroplasia are: short height, short limbs, and a prominent forehead. 8
Although spinal deformities, sleep problems and obesity are medical concerns in people with
achondroplasia, they tend to have normal intelligence and only minimal impairments in physical
ability.9 However, individuals with achondroplasia do sometimes suffer from psychological and
social issues because of their appearance. 10 Other reasons why parents with achondroplasia
would want to select embryos with achondroplasia include the ability to effectively discipline a
child and to avoid further medical complications from pregnancy and delivery of an average
sized baby.11 Lastly, parents with dwarfism are also likely concerned with their child’s feelings.
A woman with dwarfism discussed the possibility of having a child of normal height and posed
the question, “What is life going to be like for her, when her parents are different than she is?”12
Currently, there is no regulation of health care providers’ use of PGD in the United
States.13 They are essentially given “free reign to undertake PGD.”14 This obviously presents
issues when PGD reveals a genetic condition, such as achondroplasia, but the health care
provider and patient have conflicting ideas about whether or not to pursue implantation because
7

HARRY J. M ANKIN, 2 PAT HOPHYSIOLOGY OF ORT HOPAEDIC DISEASES 125 (2009).
Id.
9 Id.
10 Id.
11 Rosamund Scott, supra note 5, at 314.
12 Darshak Sanghavi, M.D., Wanting Babies Like Themselves, Some Parents Choose Genetic Defects, N.Y. TIMES,
(Dec. 5, 2006), http://www.nytimes.com/2006/12/ 05/health/05essa.html?_r=0.
13 ISABEL KARPIN AND KRIST IN SAVELL , PERFECT ING PREGNANCY: LAW , DISABILIT Y, AND T HE FUTURE OF
REPRODUCT ION 233 (2012).
14 Id. at 236.
8
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it questions not only the limits on patient autonomy but also the definition of “disability.”15
Because doctors undertake the Hippocratic Oath, an ethical dilemma can result when the patient
decides to proceed with implantation involving a genetically defective embryo. 16 Part II of this
paper will provide an overview of ART, IVF, and PGD. Part III will next explore the historical
development of reproductive freedom, inadequate ART case law in the United States, and
current oversight framework for ART, in Part III. Part IV will delve into opinions and
approaches taken by professional organizations, experts in the field, and fertility clinics. Part V
looks into doctor’s ethical obligations under the Hippocratic Oath and the dilemma that can
result when the patient decides to proceed with the implantation of a genetically defective
embryo. Lastly, Part VI provides recommendations to address these concerns.
II. ART: IVF and PGD Overview
Infertility, or the inability to become pregnant after one year of attempting to become
pregnant, affects roughly 15 percent of couples. 17 According to the Centers for Disease Control
and Prevention (CDC), six percent of married women, who are between the ages of 15-44, suffer
from infertility.18 There are several causes of infertility in women including but not limited to
ovulation disorders, abnormalities with the cervix or uterus, damage to the fallopian tubes, and
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See 22 Ill. Prac.,The L. of Med. Prac. in Ill. § 31:7 (3d ed. 2007).
See Howard Markel, “I Swear by Apollo” — On Taking the Hippocratic Oath, 350 NEW ENG. J. M ED. 2026
(2004), available at
http://search.proquest.com.ezproxy.shu.edu/docview/223941903/fulltext PDF/8C9D7074FA 7E4A CEPQ/ 1?accountid
=146984 .
17 Infertility, M EDLINE PLUS, http://www.nlm.nih.gov/medlineplus/infertility.html (last updated Nov. 3, 2014).
18 Infertility, CT RS. FOR DISEASE CONT ROL AND PREVENT ION, http://www.cdc.gov/nchs/fastats/infertility.htm (last
updated Feb. 13, 2014).
16

3

endometriosis.19 Some of the causes of male infertility are infection, ejaculation issues, hormonal
problems, and defective sperm ducts. 20
A. IVF
IVF is a type of ART that has enabled couple suffering from infertility to become
pregnant.21 IVF is the process by which female eggs, or ova, are retrieved and inseminated with
semen in a lab.22 Prior to egg retrieval, hormonal medication is administered to hyperstimulate
ovaries, which allows for the production of several eggs. 23 Once an embryo has been created, the
IVF technicians carefully monitor the embryo and will proceed with implantation when the
embryo has divided to approximately eight cells. 24 However, IVF is not only used for infertility;
another reason women undergo IVF treatment is because of genetic disorders. 25 By undergoing
IVF treatments, couples have the ability to use PGD in order to screen embryos for genetic
conditions.26 IVF and PGD are complex processes that require the collaboration of an
interdisciplinary team of professionals, are costly, and pose health risks. 27 IVF can range from
$15,000 to $17,000.28 Additionally, for those patients who undergo PGD, there is an additional
average cost of $4,500.29
B. PGD
19

Infertility: Basics, M AYO CLINIC, http://www.mayoclinic.org/diseases -conditions/infertility/basics/causes/con20034770 (last updated July 2, 2014).
20 Male Infertility: Causes, M AYO CLINIC, http://www.mayoclinic.org/diseases -conditions/maleinfertility/basics/causes/con-20033113 (last updated June 13, 2014).
21 What is Assisted Reproductive Technology, CT RS. FOR DISEASE CONT ROL AND PREVENT ION,
http://www.cdc.gov/art/ (last updated Aug. 28, 2014).
22 A NT HONY DYSON, THE ET HICS OF IVF 32 (1995).
23 Laura S. Langley, J.D. & Joseph W. Blackston, M.D., J.D., Sperm, Egg, and A Petri Dish Unveiling the
Underlying Property Issues Surrounding Cryopreserved Embryos, 27 J. LEGAL M ED. 167, 173 (2006).
24 Id.
25 Paul Brezina, supra note 3.
26 Id.
27 See infra, Part II.B; II.C.
28 Jennifer Uffalussy, The Cost of IVF: 4 Things I Learned While Battling Infertility, FORBES (Feb. 6, 2014),
http://www.forbes.com/sites/learnvest/2014/02/06/the-cost-of-ivf-4-things-i-learned-wh ile-battling-infert ility/.
29 Id.
4

There are three techniques that scientists can use to perform PGD after a patient
undergoes IVF including polar body biopsy, blastocyst biopsy, and cleavage-stage embryo
biopsy, but most clinics use the latter approach. 30 Cleavage-stage biopsy refers to the process
whereby scientists biopsy a single cell from an embryo on the third day after an egg was
retrieved.31 At this point, the embryo consists of six to ten cells. 32 This process is challenging in
that the scientists must extract a single cell with such precision to avoid harming the embryo with
micromanipulators.33 The main restriction of this approach is that the cell being evaluated may
not be indicative of the embryo’s overall genetic condition.34 Polar body biopsy refers to testing
on polar body cells that separate from the maturing egg. 35 Therefore, this technique only works
for the detection of female chromosomal disorders and does not recognize any abnormalities
after fertilization occurs.36 Blastocyst biopsy is similar to cleavage-stage embryo biopsy except
that the biopsy occurs on the fifth day after an egg was retrieved. 37 At this point, the egg is
comprised of more than one hundred cells. 38 This gives patients either the ability to select only
those embryos for implantation without genetic disorders or, alternatively, to screen for a certain
genetic condition with a known genetic profile.39

30

Molina Dayal, Preimplantation Genetic Diagnosis: Process, M EDSCAPE ,
http://emedicine.medscape.com/article/273415-overview#aw2aab6b4 (last updated Nov. 4, 2013).
31 Id.
32 Id.
33 Id.
34 Id.
35 Id.
36 Id.
37 Id.
38 Id.
39 Susannah Baruch et al., GENET ICS & PUB. POL ’Y CT R., PREIMPLANTATION GENETIC DIAGNOSIS: A DISCUSSION OF
CHALLENGES, CONCERNS, AND PRELIMINARY POLICY OPTIONS RELAT ED TO THE GENET IC TEST ING OF HUMAN
EMBRYOS 1, 3 (2004), available at
http://www.dnapolicy.org/images/reportpdfs/PGDDiscussionChallengesConcerns.pdf.
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There are many professionals involved in PGD including physicians, scientists, nurses,
genetic counselors, psychologists, and bioethicists.

40

The first type of physician employed by or

affiliated with a fertility center is a reproductive endocrinologist; these are physicians who treat
reproductive disorders and infertility. 41 In order to become a reproductive endocrinologist, one
must attend medical or osteopathic school, complete a four-year Accreditation Council for
Graduate Medical Education (ACGME)-accredited residency in obstetrics and gynecology, and
conclude with a three-year fellowship in reproductive endocrinology and infertility. 42
Another type of physician commonly found at a fertility center is a medical geneticist and
these are physicians who recognize and treat patients with genetic conditions and birth defects.43
These physicians must also undergo rigorous training; upon completion of medical school or
osteopathic school, one must complete at least 24 months of training in an ACGME-accredited
residency program in internal medicine, pediatrics, or obstetrics and gynecology.44
Scientists for a fertility center have varying educational backgrounds including but not
limited to a master’s in reproductive genetics, a Ph.D. with an emphasis in male reproductive
physiology, a Ph.D. in cytogenetics and embryology, or a PH.D. in genetics.45 PGD can be

40

See About Us, GENET ICS & IVF INST ., http://www.givf.com/aboutgivf/scientificteam.shtml (last visited Nov. 27,
2014); Team, NYU LANGONE FERT ILITY CT R., http://www.nyufertilitycenter.org/nyufc_team (last visited Nov. 27,
2014).
41 About SREI, SOC’Y. FOR REPROD. ENDOCRINOLOGY AND INFERT ILITY, http://www.socrei.org/detail.aspx?id=3142
(last visited Nov. 27, 2014).
42 Many Doctors Provide Infertility Care. How can you tell if your doctor is best qualified to take care of you?,
SOC’Y. FOR REPROD. ENDOCRINOLOGY AND INFERT ILITY,
http://www.socrei.org/uploadedFiles/Affiliates/SOCREI/Publications/SREI_brochure.pdf (last visited Nov. 27,
2014); Reproductive Endocrinology and Infertility: Fellowship Overview , M ASS. GENERAL HOSP .,
http://www.massgeneral.org/education/fellowship.aspx?id=200 (last visited Nov. 27, 2014).
43 Medical Genetics: Overview, A SS’N OF A M. M ED. COLL .,
https://www.aamc.org/cim/specialty/list/us/339986/ medical_genetics.html (last visited Nov. 27, 2014).
44 Training Options, A MERICAN BOARD OF M EDICAL GENET ICS AND GENOMICS,
http://www.abmgg.org/pages/training_options.shtml (last visited Nov. 27, 2014) (Combined programs such as
Internal Medicine/Medical Genetics are also an option).
45 See About Us, GENET ICS & IVF INST IT UTE , http://www.givf.com/aboutgivf/scientificteam.shtml (last visited Nov.
27, 2014).
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performed at the fertility center itself or conducted at an outside laboratory. 46 Scientists who
work in or with fertility clinics generally are responsible for lab services such as: sperm analysis,
storage of sperm, preserving fertility in cancer patients, IVF, PGD, and storage/cryopreservation
of eggs and embryos.47
While fertility clinics vary in their team members, most fertility clinic teams also consist
of genetic counselors, nurses, and some include psychologists. 48 Genetic counselors assist
patients in understanding genetic conditions, and they also provide counseling for patients and
their family members with genetic conditions. 49 Genetic counselors must earn a Master’s degree
in genetic counseling and pass a certification exam. 50 In order to become a nurse, one must either
obtain a bachelor’s or an associate’s degree in nursing or earn a diploma from a nursing
program.51 Additionally, registered nurses are required to be licensed. 52 Some fertility clinics
include psychologists on the team.53 Psychologists usually earn a doctoral degree in psychology
but a master’s degree in psychology also suffices for certain positions.54 Furthermore,

46

Tochi Amagwula et al., Preimplantation Genetic Diagnosis: A Systematic Review of Litigation in the Face of New
Technology. 98 FERT ILITY AND STERILITY 1277,1281 (2012), available at http://www.fertstert.org/article/S00150282(12)01836-5/pdf.
47 Lab Services, OREGON HEALT H & SCIENCE U. CT R. FOR W OMEN’S HEALT H,
http://www.ohsu.edu/xd/health/services/women/services/fertility/fertility -services/lab-services/index.cfm (last
visited Nov. 27, 2014).
48 See About Us, GENET ICS & IVF INST ., http://www.givf.com/aboutgivf/scientificteam.shtml (last visited Nov. 27,
2014); Team, NYU LANGONE FERT ILITY CT R., http://www.nyufertilitycenter.org/nyufc_team (last visited Nov. 27,
2014); Clinicians and Staff, YALE FERT ILITY CT R., http://www.yaleobgyn.org/yfc/people/index.aspx (last visited
Nov. 27, 2014).
49 About Genetic Counselors, NAT ’L . SOC’Y. OF GENET IC COUNSELORS, http://nsgc.org/p/cm/ld/fid=175 (last visited
Nov. 27, 2104).
50 How Do I Train to Become a Certified Genetic Counselor?, A M. BD. OF GENET IC COUNSELING INC.,
http://www.abgc.net/Certification/become_a_genetic_counselor.asp (last visited Nov. 27, 2014).
51 Occupational Outlook Handbook: Registered Nurses, BUREAU OF LABOR ST AT ISTICS,
http://www.bls.gov/ooh/healthcare/registered-nurses.htm (last updated Jan. 8, 2014).
52 Id.
53 Our Psychologists, NYU LANGONE FERT ILITY CT R., http://www.nyufertilitycenter.org/about-us/the-nyulfcteam/shelley-s-lee-phd (last visited Nov. 27, 2014).
54 Occupational Outlook Handbook: Psychologists, BUREAU OF LABOR ST AT ISTICS, http://www.bls.gov/ooh/lifephysical-and-social-science/psychologists.htm (last updated Jan. 8, 2014).
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psychologists who are actively practicing must be certified or licensed.55 The psychologists at a
fertility center provide emotional counseling and support for patients who are suffering from
infertility and undergoing fertility treatment.56
Bioethicists, while not typically employed by IVF clinics, are frequently consulted and
often serve on advisory committees. 57 Bioethics aims to solve moral, social, and political issues
that stem from biomedical research and the provision of health care. 58 Bioethicists strive to solve
these issues.59 Bioethicists have a diverse range of professional backgrounds and disciplines.60
Although the collective effort of each of these professionals is ideal, fertility clinics have
no standardized employee requirements. This is problematic, however, since a standardized team
approach would provide physicians with input from a diverse range of employees. This input
would be beneficial to the physician’s decision-making process for PGD-related issues. Figure 1
presents those professionals involved with PGD. 61 While this model is not representative of all
fertility center teams, it is based on a compilation of various fertility center teams throughout the
country and distinguishes between those professionals who are typically employed by or
affiliated with a fertility clinic with those professionals who are not typically found at a fertility
clinic.62 . The educational backgrounds listed are the minimum requirements. 63

55

Id.
See Our Psychologists, supra note 53.
57 See Arthur Caplan, Ph.D, NYU LANGONE DEP ’T . OF POPULATION HEALTH,
http://pophealth.med.nyu.edu/faculty/caplaa01 (last visited Nov. 27, 2014); Loretta M. Kopelman, Bioethics as a
Second-Order Discipline: Who Is Not a Bioethicist?, 31 J. OF M ED. AND PHIL. 601 (2006).
58 HET HÄYRY, INDIVIDUAL LIBERT Y AND M EDICAL CONTROL 1 (1998).
59 Id.
60 Loretta M. Kopelman, Bioethics as a Second-Order Discipline: Who Is Not a Bioethicist?, 31 J. OF M ED. AND
PHIL. 601, 602 (2006), available at http://www.tandfonline.com/doi/pdf/10.1080/ 03605310601009414 .
61 See infra Figure 1.
62
See About Us, GENET ICS & IVF INST ., http://www.givf.com/aboutgivf/scientificteam.shtml (last visited Nov. 27,
2014) (The Genetics & IVF Institute employs doctors, scientists, nurses, and genetic counselors); Team, NYU
LANGONE FERT ILITY CT R., http://www.nyufertilitycenter.org/nyufc_team (last visited Nov. 27, 2014) (The NYU
Fertility Center employs doctors, scientists, nurses, and psychologists); Clinicians and Staff, YALE FERT ILITY CT R.,
http://www.yaleobgyn.org/yfc/people/index.aspx (last visited Nov. 27, 2014) (The Yale Fertility Center team
includes physicians, nurses, scientists, and a social worker for emotional counseling); Arthur Caplan, Ph.D, NYU
56
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Figure 1 Professionals Involved with PGD64
Physicians
Education: MD or
DO Reproductive
Endocrinoogist; MD
or DO Medical
Geneticist (some of
these physicians also
have a Ph.D)
Bioethicists
Education: Ph.D, JD,
MS in Bioethics, MD,
DO
(Bioethicists come
from many
professions)

Scientists
Education: Ph.D in
Male Reproductive
Physiology,
Cytogenetics and
Embryology, or
Genetics and/or MS
in related fields

Psychologists
Education: Ph.D,
Psy.D, or MA in
Psychology

Nurses
Education: BS, RN;
BSN, RN; BS, ASN, RN

Genetic Counselors
Education: MS in
Human Genetics

Professionals Typically Employed by or Affiliated with Fertility Clinics
Professionals Not Typically Employed By or Affiliated with Fertility Clinics

LANGONE DEPART MENT OF POPULATION HEALTH, http://pophealth.med.nyu.edu/faculty/caplaa01 (last visited Nov.
27, 2014); Loretta M. Kopelman, Bioethics as a Second-Order Discipline: Who Is Not a Bioethicist?, 31 J. OF M ED.
AND PHIL. 601 (2006).
63 See Many Doctors Provide Infertility Care, supra note 42; Training Options, supra note 44; About Us, supra note
45; How Do I Train to Become a Certified Genetic Counselor, supra note 50; Occupational Outlook Handbook:
Registered Nurses, supra note 51; Occupational Outlook Handbook: Psychologists, supra note 54; Loretta M.
Kopelman, supra note 60.
64 See Id.
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C. Health Risks of IVF/PGD
The long-term health concerns of IVF and PGD are not completely known. 65 Because
IVF requires ovulation stimulation, there are risks associated with taking hormones such as
ovarian cysts and ovarian hyperstimulation syndrome (OHSS). 66 OHSS is a condition where the
ovaries swell and this can lead to mild symptoms such as abdominal bloating or severe, but rare,
symptoms such as blood clots, damage to the kidneys, or fluid accumulation in the abdomen. 67
Furthermore, there are usually multiple embryos that are transferred during IVF meaning that a
mother will likely carry more than one fetus. 68 Pregnancies with multiples are risky to the baby
and the mother.69 These babies are at an increased risk of being born prematurely, which often
results in a lower birth weight and a higher chance of being born with disabilities.70 PGD is a
difficult process that is also quite time consuming. 71 Some of the main concerns about PGD are:
false positives and false negatives, misdiagnosis resulting from contamination, and the
possibility that the removed cell is not representative of the overall genetic characteristics of the
embryo.72 Lastly, there is not much data regarding PGD and injury to the embryo from the cell
biopsy or the consequences to the development of the child.73

65

Susannah Baruch et al., supra note 39, at 3, 6.
Id.; Ovulation Induction, EMORY HEALT HCARE , http://www.emoryhealthcare.org/reproductive-center/fertilitytreatments/ovulation-induction.html (last visited Nov. 27, 2014).
67 Ovulation Induction, EMORY HEALT HCARE , http://www.emoryhealthcare.org/reproductive-center/fertilitytreatments/ovulation-induction.html (last visited Nov. 27, 2014).
68 Id.
69 Id.
70 Twins, Triplets, Multiple Births, M EDLINE PLUS,
http://www.nlm.nih.gov/medlineplus/twinstripletsmultip lebirths.html (last visited Nov. 27, 2014).
71 EMILY JACKSON, REGULAT ING REPRODUCT ION 243 (2001).
72 Id.
73 Id.
66
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III. Lack of Guidance From Current Oversight Framework and Case Law
Currently, ART in the U.S. is not fully regulated. 74 Because the federal government is not
responsible for regulating the practice of medicine, oversight rests with the states, but there are
no state laws that focus directly on PGD.75 Governmental agencies do, however, have the ability
to influence the safety of health services and products.76 Advances in technology during the
twenty-first century have created difficulties in developing a regulatory structure that can
accommodate all of the new ethical dilemmas. 77 Furthermore, intense moral disagreement exists
with respect to the appropriateness of human intrusion during the reproductive process. 78 Courts
have been hesitant to intervene with such intimate matters and individual’s decision-making.79
Furthermore, case law surrounding PGD is scant and the current oversight framework is not
robust.80 Because of the aforementioned reasons, which will be discussed further below, doctors
have little guidance when their patients want to use PGD to select genetically defective embryos.
Consequently, they are often likely forced to tackle these difficult ethical dilemmas as they are
faced with them.
A. Current Oversight Framework
Because ART is not fully regulated, current requirements offer little guidance for PGD
ethical dilemmas81 . There is no entity in the United States that gathers data on PGD practices,

74

JUDIT H A REEN, supra note 2.
Susannah Baruch et al., supra note 39, at 7, 9.
76 Id. at 7.
77 EMILY JACKSON, supra note 71, at 1.
78 Id.
79 See Skinner v. State of Okl. ex rel. Williamson, 316 U.S. 535, 536 (1942); Griswold v. Connecticut, 381 U.S. 479,
486 (1965); Eisenstadt v. Baird, 405 U.S. 438, 453 (1972); Roe v. Wade, 410 U.S. 113, 114 (1973).
80 See infra, Part III.A and Part III.C.
81 See JUDIT H A REEN, supra note 2.
75
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which makes it difficult to assess the frequency of PGD testing and for which indications it is
performed.82
In 1992, Congress passed the Fertility Clinic Success Rate and Certification Act
(FCSRCA).83 This requires all ART clinics to submit data annually to the Centers for Disease
Control and Prevention (CDC).84 The CDC then publishes the success rates of each clinic based
on the data.85 Some of the data points reported are: the procedure performed, the medical
diagnosis of the IVF patient, the number of transferred embryos, and the number of births.86
This information is publicly available on the CDC’s website which is not only beneficial for
patients who are selecting which clinic to visit but also professionals so they can monitor clinic
operation.87 There is no requirement, however, for clinics to provide information about the
babies’ health status or whether a clinic used PGD or other diagnostic tests. 88 While the
FCSRCA requires the CDC to publicly report clinic names that fail to provide data or that do not
validate the data’s accuracy, the clinics are not disciplined beyond the public reporting.89 The
lack of penalties likely provides little incentive for those noncompliant clinics to change their
behavior.

82

Susannah Baruch, J.D., Preimplantation Genetic Diagnosis and Parental Preferences: Beyond Deadly Disease , 8
Hous. J. Health L. & Pol'y 245, 252 (2008).
83 The Fertility Clinic Success Rate and Certification Act, CT RS. FOR DISEASE CONT ROL AND PREVENT ION,
http://www.cdc.gov/art/Policy.htm (last updated Oct. 31, 2013) (The CDC is a federal agency overseen by the
Department of Health and Human Services and its mission is to protect the U.S. through control and prevention of
diseases).
84 Id.
85 Id.
86 Susannah Baruch et al., supra note 39, at 7.
87 Oversight of Assisted Reprod. Tech., A M. SOC’Y. FOR REPROD. M ED. 6 (2010), available at
http://www.asrm.org/uploadedFiles/Content/About_Us/Media_and_Public_Affairs/OversiteOfART%20(2).pdf.
88 Susannah Baruch et al., supra note 39, at 7.
89 Id. at 8.
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There are three states (Florida, Massachusetts, and Michigan) that have collaborated with
the CDC to implement additional tracking methods of ART outcomes. 90 This program is known
as States Monitoring Assisted Reproductive Technology (SMART) and the aggregated data has
enabled these states to compare outcomes of births resulting from ART against those conceived
naturally.91 Because there is no penalty for clinics who fail to submit data and because states are
not required to participate in programs such as SMART, the current requirements are almost
voluntary in nature.92 This current scheme results in an inadequate overall picture and an
inability to effectively regulate ART practices.
The Food and Drug Administration (FDA) has the authority to regulate ART/ PGD
processes and several products to ensure the safety and effectiveness for human use. 93 The FDA
requires screening of reproductive tissue for communicable diseases. 94 There is mandatory
testing of the reproductive tissue for human immunodeficiency virus (HIV), hepatitis B and C,
syphilis, chlamydia, and gonorrhea. 95 Inspectors who become aware of reproductive tissue that is
infected with a communicable disease can order the tissue to be destroyed or recalled. 96 The
FDA also reviews genetic tests, which are a type of in vitro diagnostic device (IVD), to ensure

90

States Monitoring Assisted Reproductive Technology Collaborative, CT RS. FOR DISEASE CONT ROL AND
PREVENT ION, http://www.cdc.gov/art/SMART.htm (last updated July 24, 2012).
91 Id.
92 Susannah Baruch et al., supra note 39, at 8.
93 What Does FDA Do?, U.S. FOOD AND DRUG A DMIN.,
http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194877.htm (last updated Nov. 18, 2014) (The FDA
regulates foods, drugs, medical devices, radiation-emitting products, vaccines, blood & biologics, cosmetics,
tobacco products, and animal & veterinary products).
94 What You Should Know – Reproductive Tissue Donation, U.S. FOOD AND DRUG A DMIN.,
http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/TissueSafety/ucm232876.ht m (last updated Mar. 1,
2011) (Eggs and Sperm are considered reproductive tissue).
95 Id.
96 Oversight of Assisted Reprod. Tech., supra note 87.
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safety, efficacy, and design and manufacture quality of the device. 97 This oversight responsibility
is in conjunction with supervision by the Centers for Medicare and Medicaid Services (CMS)
over laboratories that perform these tests pursuant to the Clinical Laboratory Improvement
Amendments of 1988 (CLIA).98 CMS is responsible for ensuring the quality of clinical testing
processes through mechanisms such as laboratory employee credentialing and daily assurances
that devices are functioning properly.99 The complexity of IVD regulation results from the two
pathways in which they can be developed. 100 Device manufacturers can create commercial tests
that are distributed to several laboratories or a laboratory itself can create its own test for solely
its use.101 While the FDA has authority to regulate these laboratory created tests, it is often
discretionary since the tests are low risk, easy to use, and reliant on expert analysis. 102 Another
challenge rests with FDA’s lack of authority over the practice of medicine. 103 Specifically, the
FDA is not permitted to control which physicians can use a device or how those physicians use
the device.104 While the FDA does not regulate the practice of medicine, it does have the
authority to ensure that physicians are using devices that are not misbranded or adulterated. 105
Furthermore, there are three accreditation programs that can certify embryo laboratories
including the Joint Commission on Accreditation of Healthcare Organizations (JACHO), the
College of American Pathologists/American Society for Reproductive Medicine (CAP/ASRM),
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and the New York State Tissue Bank certification for ART laboratories (NYSTB). 106 The CDC
posts the accreditation information on the annual Success Rates reports. 107 These accreditation
agencies conduct unannounced, sporadic inspections to ensure compliance with: (1) standards
that ensure consistency when carrying out procedures, (2) implementation of quality assurance
programs that ensure reliable laboratory procedures, and (3) preservation of laboratory test and
procedure records.108 Laboratories that fail to comply with those standards face possible
revocation of certification.109
B. Historical Development and Reproductive Freedom
Because of the minimal ART regulation, another source of guidance for PGD ethical
dilemmas is the historical development of reproductive freedom. The constitutional right to
procreate involves not only an individual’s right to have genetically-related children by engaging
in sexual intercourse but also by using ART according to many scholars. 110 This constitutional
right to procreate is well established in case law. 111 Case law involving reproductive choices has
demonstrated a hands-off approach in the United States.112 For example, in Skinner v. Oklahoma,
a statute known as the Habitual Criminal Sterilization Act required sterilization for those
individuals who were convicted at least twice “for crimes amounting to felonies involving moral
turpitude.”113 Because Skinner was convicted of robbery on numerous occasions, the Attorney
General proceeded against Skinner so he would have to undergo a vasectomy.114 The Supreme

106

The Fertility Clinic Success Rate and Certification Act, supra note 83.
Id.
108 42 U.S.C.A. § 263a-2(d), (g) (West 1992).
109 Id. at (i).
110 JUDIT H A REEN, supra note 2, at 594.
111 See Skinner v. State of Okl. ex rel. Williamson, 316 U.S. 535, 536 (1942); Griswold v. Connecticut, 381 U.S. 479,
486 (1965); Eisenstadt v. Baird, 405 U.S. 438, 453 (1972); Roe v. Wade, 410 U.S. 113, 114 (1973).
112 Id.
113 Skinner v. State of Okl. ex rel. Williamson, 316 U.S. 535, 536 (1942).
114 Id. at 537.
107

15

Court ultimately found the statute to be unenforceable and explained that the right to procreate is
“one of the basic civil rights of man.”115 Griswold v. Connecticut was another case involving
reproductive freedom.116 This case involved a statute that banned married couples from utilizing
contraception.117 The court ultimately held that the statute interfered with a married couple’s
right of privacy.118 Similarly, in Eisenstadt v. Baird, the court struck down a Massachusetts
statute that prohibited contraceptives for unmarried individuals. 119 The court recognized that
individuals should not have to deal with government interference when making procreative
decisions under the right of privacy.120 Finally, in Roe v. Wade, the court invalidated a Texas
statute that criminalized abortion at all stages unless the mother’s life was at stake. 121 Although
the court concluded that women have a right to choose, abortions were only permitted during the
first trimester of pregnancy and with the approval of the attending physician. 122
Although history has demonstrated a hands-off approach for reproductive decisions, this
provides little guidance to physicians for the PGD dilemma. These cases are largely based on the
right to have a child, the right to prevent pregnancy, and the right to terminate pregnancy, but
none of the case law involves the specific right to use a screening test to bring a genetically
defective child into the world.123 Therefore, it is essential to look specifically at ART case law to
determine whether further guidance exists for the PGD dilemma.
C. Inadequate ART Case Law
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Unfortunately, there is not precedent from case law about the issue of using PGD to
select for genetically defective embryos. Much of the ART case law deals with issues about
parental status and issues with surrogacy agreements.124 For example, in In re Marriage of
Witbeck-Wildhagen, there was an issue about whether a man, who did not consent to his wife’s
attempt to become pregnant through artificial insemination from donor sperm, would be
recognized as the legal father for support obligation purposes after the dissolution of their
marriage.125 The court ultimately determined that because the man had not provided consent,
there was no father-child relationship.126
With respect to surrogacy agreement disputes, Matter of Baby M involved a couple, Mr.
and Mrs. Stern, who found a surrogate to carry their baby, using the surrogate’s eggs and Mr.
Stern’s sperm since Mrs. Stern had an underlying health condition that could result in a risky
pregnancy.127 Mr. Stern entered into a surrogacy agreement whereby the surrogate would get
paid after the child’s birth and delivery of the baby to the Sterns, and the surrogate would be
required to terminate all maternal rights.128 Mrs. Stern was not a party to the contract since this
would implicate the application of a statute that prohibited the use of money for adoptions.129
After giving birth, the surrogate had a difficult time parting with the child. 130 The court
ultimately found the contract to be void since it conflicted with state laws and policies against
“baby-selling” but granted custody to the Sterns since it was in the child’s best interest. 131 As it
can be seen, the aforementioned ART cases are not helpful to the PGD dilemma since they deal
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with completely different issues. Therefore, reference to PGD-specific case law may be another
source of guidance.
Lawsuits dealing specifically with PGD have largely been based on failure to provide
adequate informed consent and negligence in performing PGD. 132 Of the lawsuits involving
failure to provide adequate informed consent, individuals alleged that the fertility clinic failed to
sufficiently inform them of: errors that are inherent in PGD, the clinic’s little experience in
performing PGD, and the actual option to proceed with PGD.133 Plaintiffs can also allege
wrongful life claims in their lawsuits if the jurisdiction recognizes the cause of action. 134
Wrongful life actions are those cases where a parent of a child, who is born with a genetic
condition, sues a health care provider for failure to properly guide the parents about a possible
genetic disorder, thereby denying them the option to decide not to have the child. 135
For example, in Paretta v. Medical Offices for Human Reproduction, parents of a child
afflicted with cystic fibrosis, a “chronic, debilitating progressive genetic disease,” brought an
action against doctors for failure to properly screen (using PGD) for the disease. 136 Their claims
rested upon negligence and failure to provide proper informed consent.137 Ultimately, the court
concluded that a baby “does not have a protected right to be born free of genetic defects.”138

132

Tochi Amagwula et al., supra note 46.
Id.
134 Id.
135 Turpin v. Sortini, 31 Cal. 3d 220, 223, 643 P.2d 954, 955 (1982).
136 Paretta v. Med. Offices for Human Reprod., 195 Misc. 2d 568, 571, 760 N.Y.S.2d 639, 642 (Sup. Ct. 2003).
137 Id. at 643.
138 Id. at 646.
133

18

Based on this result, it can be implied that selecting for a genetic condition, such as dwarfism,
would not be in violation of a child’s protected right.139
Coggeshall v. Reproductive Endocrine Associates of Charlotte was a case that involved
alleged failure to provide adequate informed consent. 140 In this case, the wife underwent IVF
treatment at the clinic and subsequently had a child born with Down Syndrome.141 The condition
was discovered through amniocentesis at fourteen weeks, and the parents claimed they were
never informed of the option to undergo PGD.142 Because the parents filed suit in South
Carolina, the case was ultimately dismissed since the clinic was located in North Carolina and
the court lacked jurisdiction to hear the case. 143
In Doolan v. IVF America, (MA) Inc., a couple underwent IVF in order to avoid having a
second child with cystic fibrosis since their first child had cystic fibrosis and later genetic testing
revealed that they were both carriers of the disease. 144 After learning which embryo was free of
the genetic condition, the couple decided to proceed with implantation. 145 Shortly after giving
birth, Mrs. Doolan was informed that her son did have cystic fibrosis even though the laboratory
assured her that this embryo did not carry the gene for the disease. 146 The parents brought a
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wrongful life suit against the doctor on behalf of their son, but the court said that Massachusetts
does not recognize wrongful life claims. 147
There are simply not enough cases involving PGD and the legal theories vary. The cases
that do exist provide no direction for physicians if a patient uses PGD to select for genetic
disorders. Therefore, case law is also inadequate as a source of guidance.
IV. Positions on PGD
Another source of guidance for PGD practices rests with opinions of professional
organizations, experts in the field, and fertility clinics. However, there is a lack of explicit
guidance, differing opinions, and minimal transparency from these sources.

A. Professional Organizations
Because the practice of medicine equips physicians with a specialized skillset and
knowledge, physicians have some autonomy through self-regulation by professional
organizations.148 Despite the lack of regulation of PGD, professional organizations have issued
best practice guidelines for PGD.149 Affiliation with these professional organizations is
voluntary, so individuals who choose not to join a professional organization are not obligated to
follow the organization’s standards. 150 Even though professional organizations cannot pursue
legal actions against members who fail to abide by standards, the organizations can terminate
membership of those members and the standards can be considered “evidence of standards of
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practice in legal settings.”

151

Unfortunately, the professional organizations involved with ART

do not provide much guidance on PGD practices.
The American Society for Reproductive Medicine (ASRM) is a non-profit organization
comprised of medical, legal, and administrative professionals and special interest groups who
have an interest in infertility and reproductive medicine. 152 ASRM notes that the indication for
PGD is for “couples at risk for transmitting a specific genetic disease or abnormality to their
offspring.”153 Additionally, they recommend genetic counseling for patients prior to PGD so they
are fully informed of the ramifications of embryos with genetic conditions.154 However, there is
no guidance in this opinion for physicians when patients want to use PGD to select for a
genetically defective embryo.
The American Congress of Obstetricians and Gynecologists (ACOG) is a non-profit
organization that consists of professionals who provide women’s health care and who are
committed to advocating for quality care. 155 ACOG issued a committee opinion that notes its
outright ban on PGD for the selection of sex unless it is associated with the diagnosis of sexlinked genetic disorders.156 ACOG, like ASRM, notes the importance of genetic counselors’
involvement in the process.157 ACOG does mention the possibility of patients selecting for a
specific genetic condition, specifically dwarfism, and notes that a choice like this “seem[s] to be
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antithetical to the best interests of the future child.”158 Like ASRM, ACOG’s Committee opinion
does not offer specific guidance to that matter.159 Even though these professional organizations
have issued best practice guidelines for PGD, they are not helpful in guiding physicians when
patients want to use PGD to select for genetically defective embryos.
B. Experts in the Field
Because the professional guidelines do not offer much guidance, opinions made by
experts in the field are another resource for the PGD dilemma. This subsection includes personal
positions by experts in the field, independent from professional organization statements.
i. Physicians
Dr. Jami Grifo, M.D., Ph.D,160 is a reproductive endocrinologist affiliated with the NYU
Fertility Center and has explained that he is not against screening for a particular disorder, such
as dwarfism, and posed the following thoughts:
Two dwarfs who are happy with their lives don’t see dwarfism as a disease like
some people do. The more you think about the request, it’s not so unreasonable.
Who should make this decision?...Don’t you think a dwarf couple knows what it’s
like to be a dwarf? Why shouldn’t they be the ones to choose that, if that’s what
they want? Why should I, as a doctor, be given that authority? I don’t have the
training to be able to do that. 161
On the other hand, Dr. Robert J. Stillman, a reproductive endocrinologist of the
Shady Grove Fertility Center in Rockville, Maryland, refuses to screen for disorders such
as deafness or dwarfism and explained that, “...one of the prime dictates of parenting is to
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make a better world for our children...dwarfism and deafness are not the norm.”162 Based
on the previous opinions, it can be seen that two physicians with the same training have
such opposite viewpoints on this controversial matter. The varying viewpoints amongst
physicians likely results in their handling of issues on an off-the-cuff basis. Several case
studies have shown that “...ward ethics issues are handled, when they are handled at all,
on an ad hoc basis. The message is that these issues are not that important.”163 While
there are various differences between the ethical issues encountered in a fertility clinic
versus those encountered in a hospital ward, it is concerning that fertility clinic
physicians are likely handling these ethical dilemmas on such basis. When fertility clinics
lack the necessary policies and procedures to guide physicians in making ethical
decisions, the physicians may inevitably handle situations based on their personal beliefs.
Those physicians will likely not consult with other team members for advice if they feel
so strongly about a certain issue. Unfortunately, those instances will likely result in
patients succumbing to their physician’s beliefs, and a doctor may proceed with a plan
that lacks proper attention to the patient’s situation and needs.

ii. Scientists
The availability of scientists’ opinions about PGD selection for genetically defective
embryos is scarce. Yury Verlinksy, who earned his Ph.D. in cytogenetics and embryology, was
the founder of the Reproductive Genetics Institute. 164 He was against patients using PGD to
select for specific genetic conditions and stated,
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We are not participating in this kind of request, because our goal is to prevent
disease, not to create disease. I can't judge someone who wants to have, for
example, a Down syndrome child, but it does not have to be us to participate in it.
That is not our goal as scientists and medical professionals. 165
In an anonymously reported interview, a scientist in the UK did not directly address the
issue of using PGD for the selection of genetically defective embryos but offered insight into the
overall process of guiding patients in their selection of embryos.166 The scientist stated:
…You give them advice and you don't tell them what to do …I mean you say
the things in a way that, you know, makes it sound like, ‘this is the best one.’
Obviously in terms of morphology, you say, ‘this has got the best chance of
implanting,’ but they have to have the other information as well to make their
decision. And at the end of the day it's their embryos …So if they decide not
to have the normals put back and have the carriers, they have to live with the
decision that when that child is growing up, that child might have some
problems, but it was the one that had the nicest looking embryo …They have
to live with that decision they make. So you can't just be, ‘We think it's this
one, you should have this one.’167
Essentially, this scientist explained that with such a technical process, it is important to
fully inform patients and provide them with advice, but it is ultimately up to them to
make their final decision.168 As it can be seen, viewpoints from scientists also vary and
this can be problematic for physicians who are looking for guidance during PGD
dilemmas.

iii. Bioethicist
Arthur Caplan, PhD is the Director of the Division of Medical Ethics at NYU Langone
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Medical Center and is opposed to using PGD to screen for hereditary conditions. 169 He has
served on numerous committees and formed the Center for Bioethics and the Department of
Medical Ethics at the University of Pennsylvania. 170 Caplan’s view is as follows:
My point of view on this is medicine shouldn’t contribute to the creation of
children knowing that they're going to lack function or lack impairment that might
be viewed as normal. So I would oppose the use of PGD. I understand parents
might want that; I understand they might have wishes to form a continuity or a
bond between themselves and their children, but I don’t think medical skills
should be used to make anyone worse off. I think that’s a misuse of the testing.
It’s not a path I would see those who can do PGD pursuing. 171
Rosamund Scott, a professor of medical law and ethics who has also served on
several committees, including the Ethics Committee of the Royal College of
Obstetricians and Gynaecologists, notes that, “to grant these parents public resources to
select a child with achondroplasia would be to ensure that more instances of a given type
of difference existed but we have no obligation to replicate difference. ”172 While these
views are not representative of all bioethicists, it demonstrates some bioethicists’
opposition to selecting embryos with a particular genetic condition. As it can be seen
from the aforementioned experts, there is much variation in opinions about PGD to select
for genetically defective embryos. Therefore, guidance from experts in the field is also
not definitive.
C. Fertility Clinics
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Fertility centers do not provide much guidance on their websites with respect to their
approaches for PGD. The University of Pennsylvania’s Penn Fertility Care indicates on its
website that “embryos unaffected by the genetic or chromosomal disorder can be selected for
transfer to the uterus.”173 While the website offers no further information, it seems from this
statement that Penn Fertility Care would not allow a patient to transfer genetically defective
embryos. The San Diego Fertility Center notes on its website:

PGD makes it possible for couples with serious inherited disorders to decrease the
risk of having an affected child. PGD also can be considered for couples
experiencing repeat pregnancy loss due to genetic disorders, and for couples that
already have one child with a genetic disorder and are at high risk of having
another.174
This overview of PGD implies that the San Diego clinic only uses PGD to avoid selection of
genetically defective embryos. The University of California, Los Angeles Fertility and
Reproductive Health Center offers an even more vague explanation and approach for PGD on its
website.175 The clinic provides a brief question and answer about PGD:
Q: What is PGD and is it recommended?
A: PGD is an abbreviation for pre-implantation genetic diagnosis. It involves
removing a single cell from an embryo, usually on the third day after fertilization,
to determine if the cell or embryo is genetically normal or if the chromosomes are
balanced. It can also be used to test for specific genetic mutations if planned in
advance. There are numerous pros and cons to this procedure and an in-depth
discussion with your doctor is warranted to see if PGD is appropriate for you. 176

This vague explanation does not allow for an implication that the clinic would or would not
allow PGD use to select for genetically defective embryos. This clinic seems to prefer in person
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discussions of PGD uses between the patient and doctor as opposed to providing information on
its website.
While some fertility clinics do make their consent forms available online, the majority of
clinics do not provide public access to their policies. The lack of transparency is concerning for
two reasons. First, if patients are unable to view a fertility clinic’s consents or policies prior to
visiting a clinic, the patient will not know the fertility clinic’s approach to PGD until her actual
visit. If the patient goes for an initial consultation and feels comfortable with the fertility center
team but then later discovers that the team’s stance on PGD conflicts with her personal
viewpoint, she may decide to find another clinic. Finding another clinic may be time consuming
and frustrating for those patients. The second reason the lack of transparency is problematic is
because it makes it more difficult for other clinics to determine what constitutes best practices.
Therefore, fertility clinics are also not a helpful source of guidance for ethical issues surrounding
PGD.
Although professional organizations offer best practice guidelines, the recommendations
are quite broad and not narrowly tailored to address the PGD ethical dilemma. While experts in
the field have offered their personal opinions, they are inconsistent. Furthermore, expert opinions
of other professionals involved with PGD are not readily available. As highlighted in Figure 1,
there are several professionals involved in PGD, yet opinions of only half of the team members
are emphasized in literature.177 This is problematic since nurses, psychologists, and genetic
counselors are likely the professionals most closely involved with patients’ emotional concerns
throughout the PGD process, yet opinions based on that perspective are lacking. This emphasizes
the notion that only some of the professionals, mainly physicians, are likely to be ultimately
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responsible PGD decisions. Lastly, the lack of transparency across fertility clinics perpetuates a
culture of isolation for each clinic when collaboration across clinics could be extremely useful.

V. The Hippocratic Oath
Because professional organization statements, expert opinions, and fertility clinics offer
little guidance for PGD dilemmas, another source of ethical guidance for physicians is the
Hippocratic Oath. As Section II demonstrated, there are several professionals involved with
PGD, however, physicians seem to be the only professionals governed by an oath, which seems
logical since they have so much authority over medical decision-making.178 Even though
scientists are dealing directly with the embryos, there is no equivalent to a Hippocratic Oath for
these professionals.179 Because of this huge responsibility, physicians must take full advantage of
every resource they have when dealing with PGD ethical issues. “Given the myriad challenges
facing almost every aspect of medicine in the 21st century, the need for physicians to make a
formal warrant of diligent, moral, and ethical conduct in the service of their patients may be
stronger than ever.”180 The Hippocratic Oath, titled “Oath,” was intended for the induction of a
medical apprentice.181 Today, most medical schools integrate the recitation of a version of this
ancient Greek document at a ceremony. 182 Not only is there disagreement about when the
Hippocratic Oath was written, but there is also very little context for the Oath. 183 There are also
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several versions of the Oath but this paper will focus on the 1966 version translated by von
Staden since it is the most recent. 184 In sum, by reciting the oath, medical apprentices promised
to be good physicians.185 Furthermore, they vowed to avoid harm to their patients. 186 This section
will analyze the conflict between the physician and patient when deciding to proceed with
implantation of a genetically defective embryo while taking into consideration a doctor’s duty to
avoid harm under the Hippocratic Oath and to respect patient’s autonomy.
A. “First, Do No Harm”187
The relevant section of the oath addressing a doctor’s duty to avoid harm is as follows:
“And I will use regimens for the benefit of the ill in accordance with my ability and my
judgment, but from [what is] to their harm or injustice I will keep [them].”188 Some have argued
that this section refers to the duty of doctors to focus attention not just on their own patients but
also on public health overall.189 However, the literal meaning of this passage is that a doctor will
use his or her knowledge and skillset to ensure that no harm or injustice is inflicted upon his or
her patient.190 Depending on how the physician proceeds, the harmed patient may be the
resulting offspring or the parent, who is the paying customer.
By allowing a patient to proceed with PGD to select for genetically defective embryos, a
doctor may ultimately inflict harm on the child that is born as a result of IVF. Although parents
who have dwarfism may find it to be in their best interests to have a child with dwarfism, the

184

Id. at xiii-xiv, 193.
Id.
186 Sheila McLean, 31 First Do No Harm (2006).
187 Finucan v. Maryland State Bd. of Physician Quality Assur., 151 Md. App. 399, 417, 827 A.2d 176, 187 (2003)
(While this phrase is not explicitly contained in the Hippocratic Oath, it is a saying familiar to all doctors).
188 Steven H. Miles, supra note 181, at xiii.
189 Id. at 62.
190 See id.
185

29

child could end up being harmed. While people with dwarfism can have fully functional lives
and occasionally only suffer from psychological and social issues as noted earlier, the child who
is brought to this world may resent the fact that the parents and the doctor were aware of the
disability yet brought him or her to the world anyway. 191 This may also open the floodgates of
wrongful life actions by the child against the patients and/or the doctors if the child is in a
jurisdiction that recognizes those actions.192 However, if the doctor does now allow a patient to
proceed with PGD to select for genetically defective embryos, the doctor may ultimately harm
the patient. As mentioned earlier, because there has been such an emphasis on reproductive
freedom throughout history, this action by a doctor may be seen as interference with the
fundamental right to privacy.193 In the end, the doctor struggles in determining whose best
interests are at stake –the parent who wants a “genetic connection” with a child sharing the same
disability as the parent or the resulting child who will be afflicted with a genetic condition that
could have been avoided.194 Because the doctor could be inflicting harm in either instance, this
section of the Oath does not offer much guidance and results in an ethical dilemma for a doctor.
B. Patient Autonomy
In ancient Greece, the physician-patient relationship was paternalistic according to most
modern medical ethicists; the physician made decisions without consulting with the patient since
patients were unable to handle bad news. 195 However, in today’s society, it is essential for the
physician-patient relationship to include the patient in the medical decision-making process
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through patient education, informed consent, and candid discussions about diagnosis and
treatment.196 There is now respect for patient’s autonomy in medical decision-making.197
Because of this need to respect patient autonomy, a physician must now balance this with his or
her duty to provide the best possible care to patients while avoiding harm. 198 While it may be
comfortable for some physicians working at fertility centers to take an ancient Greek,
paternalistic approach with their patients who want to proceed with implantation of genetically
defective embryos, they must be mindful that patient autonomy is important, especially with
such a personal decision.199
Personal decision-making, however, should not cause a physician to stray away from his
duties under the oath. A reproductive endocrinologist indicated in an off-the-record interview
that one of his patients, who had achondroplasia, told him that if he did not allow her to select
embryos affected with achondroplasia for implantation, she would go to another clinic for IVF
treatment but refuse PGD.200 She also said that she would undergo amniocentsis and threatened
to abort any fetuses unaffected by achondroplasia. 201 Because the physician did not want to be
responsible for a possible abortion, he proceeded with PGD. 202 As noted earlier, the main
purpose of the oath is based on the promise to be a good physician and avoid harm.203 Making
medical decisions because of duress seems to undermine the whole purpose of the oath.
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Although the Oath is still widely taken as noted earlier, its literal meaning deviates from
the current state of medicine with respect to patients’ autonomy. 204 This can cause another
obstacle for physicians when confronting complex ethical issues. For example, one section of the
oath states, “And likewise I will not give a woman a destructive pessary.”205 In ancient Greece,
vaginal pessaries, devices that are used to support the uterus or bladder and rectum, were
commonly utilized.206 The type of pessary referred to in the Oath is one that caused an
abortion.207 Although abortion was legal in ancient Greece, some argue that this passage is
evidence of condemnation of abortion. 208 During this time in Greece, women did not have the
authority to make their own medical decisions; instead, their husbands or fathers made their
medical decisions.209 “This dependence of women [on men] had profound implications for the
physician-patient- guardian relationship in gynecology and can even be seen in the gynecological
theories themselves.”210
Even though refusal to proceed with the implantation of genetically defective embryos is
not the same as abortion, this passage from the Oath is relevant because of the progress in
women’s independence for gynecological matters. The decision to conduct PGD and ultimately
whether or not to proceed with implantation of a genetically defective embryo is no longer the
sole decision of a male as was the case in ancient Greece. 211 By not allowing a patient to proceed
with implantation of a genetically defective embryo, this could be viewed as reverting back to
the paternalistic relationship between physicians and patients. Physicians involved in PGD
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should be conscious of this because imposing their personal decisions on a patient will deprive
her of her autonomy. PGD should be a shared decision-making process between the patient, her
partner or spouse (if applicable), and the doctor. The physician should, of course, intervene and
not allow the patient’s proposed suggestions if the harms in proceeding with the PGD
significantly outweigh the benefits. Although the Oath is an ethical source of reliance for
physicians, the aforementioned reasons highlight the struggle that physicians have when they try
to fulfill their duties under the oath while still maintaining respect for patient’s autonomy.
Therefore, the Hippocratic Oath also offers inadequate guidance to physicians when facing PGD
ethical dilemmas.

VI. Recommendations
Because professional organizations, experts in the field, and fertility clinics have not been
specific with their approaches and opinions, definitive guidance is needed for PGD and the
selection of genetically defective embryos. Accordingly, the recommendations to address the
dilemma that can arise when a patient wants to pursue implantation of a genetically defective
embryo are: the implementation of a robust ethics curriculum in medical school and residency,
the implementation of comprehensive fertility clinic protocols, PGD reporting requirements, and
fertility clinic team standardization.
A. PGD Reporting Requirements
Because no entity gathers data on PGD practices, the CDC should use this as an
opportunity to take leadership and encourage clinics to provide PGD data. 212 Although many
clinics would find the extra data submission to be burdensome, the CDC could educate clinics
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about the importance of transparency. The transparency on CDC’s website about PGD
indications would provide physicians with further guidance. The CDC could work with the
accreditation agencies to ensure that the PGD data submission requirement is addressed during
clinic inspections. Engaging multiple entities in the encouragement of PGD data submission will
likely emphasize the importance of this practice.
B. Implementation of Robust Ethics Curriculum in Medical Schools and Residency
Since physicians have such differing approaches to PGD for the selection of genetically
defective embryos, they are likely handling matters on an ad hoc basis as mentioned earlier. 213 In
order to avoid this approach, it is essential that these ethical issues are addressed early in a
physician’s career and that fertility clinics are fully equipped to handle these matters. Tackling
this issue of proper ethical decision-making during the initial training stages of a doctor’s career
is one way to address the PGD dilemma.
According to one survey, there lacks a uniform standard amongst medical schools for
ethics-based courses.214 In this study, surveys were sent to 125 U.S. medical schools and 16
Canadian medical schools to assess their overall ethics education. 215 Of the schools that
participated in the survey, only 55% reported that an introductory course devoted to ethics
existed in the curriculum.216 Reasons for the deficiency in of ethics-based courses in medical
school were attributable to: little time in the curriculum, not enough teachers available, and
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insufficient time in faculty members’ schedules.217 As previously mentioned, medical students
undertake the Hippocratic Oath and promise to be good physicians. 218 Because medical school is
the foundation for physicians’ training, it is essential that doctors not only receive proper
education in the sciences but also in ethics. If a medical school is not providing enough ethicsbased courses or ethics training in its curriculum and during rotations, how will a medical student
be fully equipped to be a “good physician?” Being a good physician does not necessarily mean
only succeeding in medical school and advancing to clinical practice where one is able to
correctly diagnose and treat patients. Being a good physician also requires one to understand
ethical issues surrounding patient care and apply what he or she learned in ethics-based
curriculum to a particular situation.
Implementing a robust ethics-based training program in medical school is not the only
solution. During residency, ethics-based training should also be a priority. If medical schools are
not providing this foundation, then medical residents will struggle as they have more frequent
interactions and responsibilities with patients. Residency programs, especially in those fields
where ethical issues tend to arise, should strive to incorporate ethics into the training. Johns
Hopkins is one medical center that integrates a strong ethics curriculum in its surgery, pediatrics,
and medicine residency programs.219 Margaret Moon is an Assistant Professor of General
Pediatrics and Adolescent Medicine and has been instrumental in creating the ethics program. 220
She explained that attending surgeons provided positive feedback during the implementation
phase of the ethics program and many of them agreed that ethical skills are just as important as
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learning surgical skills.221 Examples of the curriculum include ethics case-based discussions
during noon conference, morning ethics conferences held seven to eight times each year, and
weekly support groups facilitated by an attending physician where residents address ethical
issues.222 This program has been in place for five years and those participating residents have
expressed an increase in their levels of confidence when dealing with patients and ethical
issues.223 The more practice that residents have with ethics-related issues, the better equipped
they will be when they are handling these matters alone after completion of their training and
without the supervision of an attending physician.
C. Establishment of Comprehensive Fertility Clinic Protocols
The second recommendation involves ensuring that fertility clinics have implemented
necessary protocols for PGD. The importance of policies and procedures are noted in a case
study that concerned a resident intern at a French hospital who was involved in the care of an
HIV positive man whose health had completely deteriorated. 224 The patient was in septic shock
and there was uncertainty as to whether or not his life support should be withdrawn.225 The
attending physician took it upon himself to withdraw life support without consulting with the
medical team or family and “project[ed] his own interests and values on the patient.”226 The
commentary on this case study noted, “One cannot order a person to change his personality or to
automatically stop believing in the paternalistic responsibilities of the physician. But one can
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adopt policies or procedures...”227
While this case involves an HIV positive man and extreme circumstances that would
hopefully never happen in the United States, it emphasizes the point that physicians should not
impose their beliefs and values on their patients. Implementation of necessary policies and
procedures would ensure that physicians would have to abide by standards rather than only
making personal decisions for the patient. Of course, there will likely be unique situations that
may not conform to the requirements of a protocol. In those instances, a physician should use the
proper medical judgment and collaborate with other staff members. Furthermore, when creating
these protocols, fertility clinics should rely on the input of all team members. For example, even
though physicians are in the frontlines of care, they may not consider certain factors dealing with
PGD that a fertility center scientist would consider. Because the team members have a diverse
range of educational backgrounds and work experience, their collective input will allow for a
protocol that will address a multitude of issues and scenarios dealing with PGD.228
Collaboration with internal team members is not the only way to establish comprehensive
protocols. Although fertility clinics across the country technically are competitors, they should
strive to work with one another by enhancing transparency across clinics. Clinics could achieve
this by simply posting their procedures and protocols on their website. If clinics made their
policies and consent forms more readily available, this would allow for greater collaboration
between clinics in tackling the PGD ethical dilemmas. Clinics could also collaborate at
conventions and present case studies to share their own experiences and how they handled PGD
ethical dilemmas. Furthermore, the clinics could work with organizations like ACOG and ASRM
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to improve best practice guidelines so additional guidance on PGD for selection of genetically
defective embryos is established.229
In the event that a particular case falls outside the scope of a policy or procedure, it could
be referred to an ethics committee. At Albert Einstein College of Medicine’s Montefiore Medical
Center, any patients who request PGD for “family balancing,” or sex selection that is not based
on any medical indication, must have their case presented to the medical school’s ethics
committee.230 The committee balances the risks of PGD against the couple’s justification for the
procedure.231 Until the committee makes a decision, there will be no treatment provided. 232 For
fertility centers that are affiliated with an academic medical institution, this additional safeguard
will provide them with further support in their decision-making process. This is similar to an
Institutional Review Board, which is primarily responsible for ensuring that research involving
human subjects is conducted appropriately and ensuring that subjects’ rights are not
compromised.233 If a patient wanted to proceed with PGD to select for genetically defective
embryos, the ethics committee would assemble and review the patient’s circumstances while
taking the doctor’s medical judgment into consideration.234 After the committee has carefully
reviewed the case and completed a risk benefit analysis, it would provide its overall
recommendation to the physician about how to proceed. 235 Because revisions in policies often do
not happen until circumstances arise that warrant the revisions, a particular case and the
committee’s suggestion could be helpful in making any necessary modifications to clinic
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protocols and policies.
In conclusion, ensuring the proper foundation in medical school and residency is not
enough. Fertility clinics must also continue the necessary oversight through protocols to ensure
that PGD is being performed in an ethically sound manner. Furthermore, clinics affiliated with
academic medical centers should take advantage of the resources they already have to ensure that
PGD issues are handled appropriately.
D. Fertility Clinic Team Standardization
Because there is a lack of uniformity in the composition of fertility team members across
clinics, standardization requirements by accreditation agencies or states would foster a more
collaborative approach to ethical issues encountered at fertility clinics. A standardized fertility
team composition would ease the heavy decision-making burden on physicians for ethical
dilemmas. Ensuring that professionals such as psychologists and bioethicists, who are not
typically employed by or affiliated with fertility clinics, become a required component of fertility
clinics would provide further guidance for physicians.236 This standardization requirement would
likely bolster the credibility of expert opinions by other professionals involved in PGD whose
expert opinions are not readily available in literature. If expert opinions by professionals not
typically employed by or affiliated with fertility clinics were more readily available, physicians
would have comprehensive guidance when dealing with PGD dilemmas. When accreditation
agencies such as JACHO perform their surveys of fertility clinics, fertility team composition
could be another required area to assess. 237 If states also mandated standardized fertility clinic
team members, the dual intervention would ensure adherence with requirements. While some
236
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may disagree with the necessity of requiring professionals such as bioethicists at fertility clinics,
the interdisciplinary approach would likely prove to be extremely beneficial for the fertility
clinic providers on the frontlines of care.
VII. Conclusion
ART has enabled many people, incapable of conceiving, to become parents. 238
Unfortunately, these new technologies raise many ethical concerns, and it is difficult to address
all of these concerns through regulation. 239 It is not surprising that some couples may use PGD to
select genetically defective embryos in order to have a “genetic connection” to their children. 240
Because PGD is a costly procedure that poses health risks to patients, physicians should strive to
ensure safety for their patients, while still maintaining respect for their autonomy.241
Unfortunately, many doctors are not prepared to handle complex ethical cases when a
patient wants to use PGD to select genetically defective embryos. The current oversight
framework of PGD and positions from professional organizations, experts in the field, and
fertility centers provide little guidance.242 Additionally, although there is vast range of health
care professionals involved with PGD, many clinics across the country only employ physicians,
scientists, nurses, and genetic counselors.243 Despite the fact that several professionals are
involved with PGD, the heavy ethical decision-making burden seems to fall on physicians.
Physicians owe a duty to their patients to be good physicians and this can be accomplished by
being well rounded.244 By building a foundation in ethics during medical school and residency,

238

See What is Assisted Reproductive Technology, supra note 21.
Emily Jackson, supra note 71.
240 See Rosamund Scott, supra note 5.
241 See Jennifer Uffalussy, supra note 28; Ovulation Induction, supra note 67.
242 See supra, Section III.
243 See About Us, supra, note 62.
244 See ST EVEN H. M ILES, supra note 181, at 3.
239

40

physicians will be more prepared to handle these complex ethical issues.
Improving the ethics training during medical school and residency is not the only
solution, however. Standardization of fertility center teams would also provide physicians with
input from a diverse group of professionals, thereby eliminating independent decision-making
for such complex ethical issues. Physicians could easily collaborate with all team members on
such complex matters if they were all housed in the clinic. Additionally, fertility clinics affiliated
with academic medical centers would greatly benefit if they consulted with the ethics
committees.245 This collaboration would also allow for the proper implementation of
comprehensive protocols and practices. Physicians would also benefit immensely from
transparency between fertility clinics. Collaboration across clinics and with professional
organizations would also further develop best practice guidelines. Lastly, the CDC should add
data points about PGD on their website so physicians could easily refer to other clinic
approaches for PGD indications. In conclusion, deploying each of the aforementioned
recommendations would likely help physicians during PGD ethical dilemmas.
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